Health Secretary Kennedy Backs Peptides His FDA Is Reviewing

On July 23–24, 2026, an FDA advisory panel reviews seven peptides — short protein fragments that pharmacies can compound, or customize, for patients. Health Secretary Kennedy, who oversees the FDA, has endorsed them, disclosed personal use with "really good effect," and accused the agency of waging "war on public health." FDA briefing documents cite inadequate evidence of safety or effectiveness.